Trivalent CAR T cells mitigate CD19-negative relapse and improve tumor control in primary pre-B cell acute lymphoblastic leukemia (B-ALL)

被引：0
|
作者：
Fousek, Kristen [1 ]
Watanabe, Junji [2 ]
An, Xingyue [3 ]
George, Ann [2 ]
Samaha, Heba [1 ]
Navai, Shoba [1 ]
Byrd, Tiara T. [1 ]
Kirzner, Jonathan [2 ]
Kim, Hye Na [2 ]
Jang, Albert [1 ]
Joseph, Sujith [1 ]
Baker, Matthew [1 ]
Hegde, Meenakshi [1 ]
Varadarajan, Navin [3 ]
Heisterkamp, Nora [2 ]
Abdel-Azim, Hisham [2 ]
Ahmed, Nabil [1 ]
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
[2] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA
[3] Univ Houston, Houston, TX USA
来源：
CANCER IMMUNOLOGY RESEARCH | 2018年 / 6卷 / 09期
关键词：
D O I：
10.1158/2326-6074.TUMIMM17-A50
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A50
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Targeting Primary Pre-B Cell Acute Lymphoblastic Leukemia and CD19-Negative Relapses Using Trivalent CAR T Cells
    Fousek, Kristen
    Watanabe, Junji
    George, Ann
    An, Xingyue
    Samaha, Hebatalla
    Navai, Shoba Alaska
    Byrd, Tiara T.
    Jang, Albert
    Kim, Hye Na
    Joseph, Sujith
    Baker, Matthew
    Varadarajan, Navin
    Hegde, Meenakshi G.
    Kim, Yong-Mi
    Heisterkamp, Nora
    Abdel-Azim, Hisham
    Ahmed, Nabil
    BLOOD, 2017, 130
  • [2] Targeting CD19-Negative Relapsed B-Acute Lymphoblastic Leukemia Using Trivalent CAR T Cells
    Fousek, Kristen
    Watanabe, Junji
    George, Ann
    Byrd, Tiara
    An, Xingyue
    Samaha, Hebatalla
    Salsman, Vita
    Navai, Shoba
    Jang, Albert
    Kim, Hye Na
    Joseph, Sujith
    Baker, Matthew
    Varadarajan, Navin
    Hegde, Meenakshi
    Kim, Yong-Mi
    Heisterkamp, Nora
    Abdel-Azim, Hisham
    Ahmed, Nabil
    MOLECULAR THERAPY, 2018, 26 (05) : 298 - 298
  • [3] Targeting CD19-negative relapsed B-acute lymphoblastic leukemia using trivalent CAR T cells.
    Fousek, Kristen
    Watanabe, Junji
    George, Ann
    An, Xingyue
    Samaha, Heba Samir
    Navai, Shoba Alaska
    Byrd, Tiara T.
    Jang, Albert
    Kim, Hye Na
    Joseph, Sujith
    Baker, Matthew
    Varadarajan, Navin
    Hegde, Meenakshi G.
    Kim, Yong-Mi
    Heisterkamp, Nora
    Abdel-Azim, Hisham M.
    Ahmed, Nabil M.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
  • [4] CD19 CAR T Cells for the Treatment of Pediatric Pre-B Cell Acute Lymphoblastic Leukemia
    Pacenta, Holly L.
    Laetsch, Theodore W.
    John, Samuel
    PEDIATRIC DRUGS, 2020, 22 (01) : 1 - 11
  • [5] CD19 CAR T Cells for the Treatment of Pediatric Pre-B Cell Acute Lymphoblastic Leukemia
    Holly L. Pacenta
    Theodore W. Laetsch
    Samuel John
    Pediatric Drugs, 2020, 22 : 1 - 11
  • [6] Single-cell profiling identifies pre-existing CD19-negative subclones in a B-ALL patient with CD19-negative relapse after CAR-T therapy
    Rabilloud, Tracy
    Potier, Delphine
    Pankaew, Saran
    Nozais, Mathis
    Loosveld, Marie
    Payet-Bornet, Dominique
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [7] Single-cell profiling identifies pre-existing CD19-negative subclones in a B-ALL patient with CD19-negative relapse after CAR-T therapy
    Tracy Rabilloud
    Delphine Potier
    Saran Pankaew
    Mathis Nozais
    Marie Loosveld
    Dominique Payet-Bornet
    Nature Communications, 12
  • [8] Lineage Switch As a Relapse Mechanism of Pre-B Acute Lymphoblastic Leukemia Following CD19 CAR
    Jacoby, Elad
    Nguyen, Sang Minh
    Welp, Kathryn M.
    Qin, Haiying
    Yang, Yinmeng
    Chien, Christopher Daniel
    Shern, John
    Fry, Terry J.
    BLOOD, 2015, 126 (23)
  • [9] CD19-Negative B-ALL Relapses after CAR T Cell Therapy are Associated with a Hypermutator Phenotype
    Yang, Guang
    Faude, Sophia
    Paessler, Michele
    Wertheim, Gerald
    Pillai, Vinodh
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1410 - 1411
  • [10] CD19-Negative B-ALL Relapses after CAR T Cell Therapy are Associated with a Hypermutator Phenotype
    Yang, Guang
    Faude, Sophia
    Paessler, Michele
    Wertheim, Gerald
    Pillai, Vinodh
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1410 - 1411
12345